Fangzhou Inc. Recognized in AI Healthcare Technology
Fangzhou Inc. (“Fangzhou”) (06086.HK), a prominent player in Internet healthcare solutions, has been honored at the 2024 Guangdong “AI Catalyst” Enterprise Billboard during the Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference. The recognition highlights the company’s efforts in leveraging AI technology for online healthcare and chronic disease management.
Mr. Xie Fangmin, CEO of Fangzhou, expressed gratitude for the recognition, stating, ‘We are honored to be recognized as an AI technology innovator. This acknowledgment reflects our commitment to improving healthcare through technological advancement and our dedication to providing exceptional service to patients and healthcare providers alike.’
Guangdong’s AI Initiatives
Guangdong is making strides in AI applications across various sectors. In May, the province introduced ‘Measures for Empowering Various Industries with Artificial Intelligence,’ aiming to establish over 500 AI-driven application scenarios in manufacturing, education, and senior care. This initiative continued with the ‘Action Plan for Promoting High-Quality Development of Guangdong’s Life Sciences Industry,’ which outlines measures to reaffirm the region as a biotech hub.
About Fangzhou Inc.
The company stands as China’s leading online chronic disease management platform, boasting 45.6 million registered users and 217,000 registered doctors as of June 30, 2024. Fangzhou aims to personalize medical care and precision medicine for a growing number of chronic disease patients.
About the Industry Conference
The 2024 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference, held on October 23rd in Nansha, Guangzhou, gathered over 1,000 leaders from various domains to discuss the latest AI trends.
